Laurent MBA - AB Science Chief Officer
| AB Stock | EUR 0.78 0.01 1.27% |
Insider
Laurent MBA is Chief Officer of AB Science SA
| Phone | 33 1 47 20 00 14 |
| Web | https://www.ab-science.com |
AB Science Management Efficiency
The company has return on total asset (ROA) of (0.4329) % which means that it has lost $0.4329 on every $100 spent on assets. This is way below average. AB Science's management efficiency ratios could be used to measure how well AB Science manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Emilie Desodt | Genfit | 40 | |
| Elsa Borghi | Nanobiotix SA | N/A | |
| Pr Staels | Genfit | 60 | |
| Laurent Levy | Nanobiotix SA | 50 | |
| Grgory Meiffren | Adocia | N/A | |
| Franois Romagn | Innate Pharma | 59 | |
| Marc Bonneville | Innate Pharma | 63 | |
| Odile Belzunce | Innate Pharma | 43 | |
| Grard Soula | Adocia | 78 | |
| Pascal Caisey | Genfit | 55 | |
| Bart Rhijn | Nanobiotix SA | N/A | |
| Kathryn McNeil | Nanobiotix SA | 48 | |
| AnneJuliette MA | Nanobiotix SA | 49 | |
| Pascal Prigent | Genfit | 55 | |
| DVM MBA | Innate Pharma | 58 | |
| Mondher MD | Innate Pharma | 65 | |
| Olivier MBA | Adocia | 53 | |
| Pr Prasad | Nanobiotix SA | 78 | |
| Alessandro MD | Innate Pharma | N/A | |
| Stefanie Magner | Genfit | 42 | |
| JeanChristophe Marcoux | Genfit | 46 | |
Management Performance
| Return On Asset | -0.43 |
AB Science SA Leadership Team
Elected by the shareholders, the AB Science's board of directors comprises two types of representatives: AB Science inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AB Science. The board's role is to monitor AB Science's management team and ensure that shareholders' interests are well served. AB Science's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AB Science's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Harshad KULKARNI, Head Statistics | ||
| Alain MBA, Chairman, CoFounder | ||
| Yves MD, Head Pharmacovigilance | ||
| Laurent MBA, Chief Officer | ||
| Alexis BERNARD, Head Sales | ||
| Albert DVM, Pres Operations | ||
| Christian FASSOTTE, Global Officer |
AB Science Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is AB Science a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.43 | |||
| Operating Margin | (12.22) % | |||
| Current Valuation | 427.66 M | |||
| Shares Outstanding | 46.86 M | |||
| Shares Owned By Insiders | 41.25 % | |||
| Shares Owned By Institutions | 1.79 % | |||
| Price To Earning | (10.99) X | |||
| Price To Sales | 193.66 X | |||
| Revenue | 1.61 M | |||
| Gross Profit | 1.5 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in AB Science Stock
AB Science financial ratios help investors to determine whether AB Science Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AB Science with respect to the benefits of owning AB Science security.